Trial · NCT02760862
Comparative Study Between Hydrocortisone and Mannitol in Treatment of Postdural Puncture Headache
NCT02760862, Phase 4, Completed, Ain Shams University; results first posted 2020-08-25
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Comparative Study Between Hydrocortisone and Mannitol in Treatment of Postdural Puncture Headache. Trials, record NCT02760862. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02760862
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Comparative Study Between Hydrocortisone and Mannitol in Treatment of Postdural Puncture Headache
- NCT number
- NCT02760862
- Status
- Completed
- Phases
- Phase 4
- Enrollment
- 50 participants, actual
- Lead sponsor
- Ain Shams University
- Conditions
- Headache
- Interventions
- hydrocortisone 100mg., mannitol 20% intravenous fluid
- First posted
- 2016-05-04
- Last updated
- 2020-08-25
- Results first posted
- 2020-08-25
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of Patients (in Digits) Got Earlier Relief of PDPH (in Hours) After Use of Hydrocortisone or Mannitol. | within 48 hours after starting of treatment |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number of Patients (in Digits) Got Earlier Relief of PDPH (in Hours) After Use of Hydrocortisone or Mannitol. | within 48 hours after starting of treatment | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.gov
Results by group2
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Patients (in Digits) Got Earlier Relief of PDPH (in Hours) After Use of Hydrocortisone or Mannitol. | Group (I) (N=25) | 25 | Participants | ||
| Number of Patients (in Digits) Got Earlier Relief of PDPH (in Hours) After Use of Hydrocortisone or Mannitol. | Group (II) (N=25) | 25 | Participants |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Group (I) (N=25) | 25 | |
| Overall Study | STARTED | Group (II) (N=25) | 25 | |
| Overall Study | COMPLETED | Group (I) (N=25) | 25 | |
| Overall Study | COMPLETED | Group (II) (N=25) | 25 | |
| Overall Study | NOT COMPLETED | Group (I) (N=25) | 0 | |
| Overall Study | NOT COMPLETED | Group (II) (N=25) | 0 |
Source ClinicalTrials.gov
Adverse events2
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | flushing | Skin and subcutaneous tissue disorders | Group (I) (N=25) | 2 | 25 | |
| other | flushing | Skin and subcutaneous tissue disorders | Group (II) (N=25) | 0 | 25 |
Source ClinicalTrials.gov
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Group (I) (N=25) | ||
| Total, all-cause mortality | Group (II) (N=25) | ||
| Total, other adverse events | Group (I) (N=25) | 2 | 25 |
| Total, other adverse events | Group (II) (N=25) | 0 | 25 |
| Total, serious adverse events | Group (I) (N=25) | 0 | 25 |
| Total, serious adverse events | Group (II) (N=25) | 0 | 25 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons2
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Group (I) (N=25) vs Group (II) (N=25): Number of Patients (in Digits) Got Earlier Relief of PDPH (in Hours) After Use of Hydrocortisone or Mannitol. | Trial comparisons |
| Group (I) (N=25) vs Group (II) (N=25): serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02760862
GET https://conductscience.org/api/trials/v1/NCT02760862/registered